Document is current
Any future updates will be listed below
-
Authors
Rizas, Konstantinos D. https://orcid.org/0000-0002-5993-0339
Freyer, Luisa
Sappler, Nikolay
von Stülpnagel, Lukas https://orcid.org/0000-0003-2238-2815
Spielbichler, Peter
Krasniqi, Aresa
Schreinlechner, Michael
Wenner, Felix N.
Theurl, Fabian https://orcid.org/0000-0002-0190-5958
Behroz, Amira
Eiffener, Elodie https://orcid.org/0000-0001-5971-4903
Klemm, Mathias P.
Schneidewind, Annika
Zens, Martin
Dolejsi, Theresa
Mansmann, Ulrich https://orcid.org/0000-0002-9955-8906
Massberg, Steffen https://orcid.org/0000-0001-7387-3986
Bauer, Axel https://orcid.org/0000-0001-9201-8555
-
Funding
Funding for this research was provided by:
Ludwig-Maximilians-University Munich, Germany Pfizer Pharma GmbH, Germany
- License Information
-
More Information
Article History
Received: 2 July 2022
Accepted: 28 July 2022
First Online: 28 August 2022
Competing interests
: All authors declare no competing interests with respect to the study or the products investigated in the study. None of the authors has a financial, academic or intellectual property conflict of interest with the mobile app company Preventicus.
